Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cognition Care DW2009
- Development stage
- Unknown
- Lead developer
- Dongwha Pharmaceutical
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral
01
Overview
Cognition Care DW2009 is a health functional food ingredient developed by Dong Wha Pharm, consisting of a complex of the probiotic strain *Lactiplantibacillus plantarum* C29 (formerly *Lactobacillus plantarum* C29) and fermented soybean powder. It is specifically designed to improve cognitive function in individuals experiencing mild cognitive impairment (MCI) or age-related cognitive decline. The product's mechanism of action involves the modulation of the gut-brain axis, which leads to an increase in the expression of brain-derived neurotrophic factor (BDNF), a critical protein for neuronal survival, memory, and learning. In addition to its neuroprotective effects, DW2009 supports intestinal health by balancing the gut microbiota, suppressing harmful bacteria, and promoting regular bowel movements.
- Brand names
- Cognition Care DW2009
- Other names
- Lactobacillus plantarum C29-fermented soybean productDW2009 probioticDW-2009 probioticDW 2009 probiotic
02
Targets
BDNF (Brain-derived neurotrophic factor)
Beyond the preview
Go deeper on Cognition Care DW2009.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cognition Care DW2009.